ABSTRACT Nineteen tyrosine auxotrophs of the ciliated protozoan Tetrahymena thermophila.have been isolated and biochemically examined. These mutants are defective in the conversion of phenylalanine to tyrosine; this is analogous to the defect that causes phenylketonuria in humans. After nitrosoguanidine mutagenesis and self-fertilization, progeny clones were screened for tyrosine auxotrophy and positively identified by using growth tests and in vivo radiometric assays for phenylalanine-to-tyrosine conversion. Mutants in one complementation group (locus) lacked phenylalanine hydroxylase activity; mutants in three other loci appeared to be deficient in the unconjugated pteridine cofactor that is necessary for the function of the hydroxylase. Another mutant lacked the dihydropterine reductase activity required toregenerate the reduced form of the pteridine cofactor. Because hydroxylation of tyrosine to dopa and of tryptophan to 5-hydroxytryptophan may require the same cofactor and pterin reductase as phenylalanine hydroxylase, these mutants may also prove useful for the study ofthe role ofcatecholamines and serotonin, substances known to be present in Tetrahymena
ABSTRACT Nineteen tyrosine auxotrophs of the ciliated protozoan Tetrahymena thermophila.have been isolated and biochemically examined. These mutants are defective in the conversion of phenylalanine to tyrosine; this is analogous to the defect that causes phenylketonuria in humans. After nitrosoguanidine mutagenesis and self-fertilization, progeny clones were screened for tyrosine auxotrophy and positively identified by using growth tests and in vivo radiometric assays for phenylalanine-to-tyrosine conversion. Mutants in one complementation group (locus) lacked phenylalanine hydroxylase activity; mutants in three other loci appeared to be deficient in the unconjugated pteridine cofactor that is necessary for the function of the hydroxylase. Another mutant lacked the dihydropterine reductase activity required toregenerate the reduced form of the pteridine cofactor. Because hydroxylation of tyrosine to dopa and of tryptophan to 5-hydroxytryptophan may require the same cofactor and pterin reductase as phenylalanine hydroxylase, these mutants may also prove useful for the study ofthe role ofcatecholamines and serotonin, substances known to be present in Tetrahymena Phenylketonuria is a hereditary human disease caused by a deficiency in the enzymatic conversion of phenylalanine to tyrosine. This deficiency can result from a lack ofany one ofat least three components: phenylalanine hydroxylase, which directly converts phenylalanine to tyrosine (1) (2) (3) ; tetrahydrobiopterin, which acts as a hydrogen donor in the hydroxylation (4); and dihydropteridine reductase, which catalyzes the conversion ofoxidized dihydrobiopterin to its active tetrahydro form (5) . The biochemical and clinical aspects of this disease have been extensively studied (6, 7) .
The ciliated protozoan Tetrahymena is a useful, animal-like model system for the isolation and study oftyrosine auxotrophs. Recently developed methods for efficient isolation of recessive mutants in Tetrahymena (ref. 8; unpublished data) make possible the isolation of biochemical mutants. The ease of biochemical and genetic manipulation of this organism allows a quick and detailed analysis of the mutation in question.The nutritional requirements for Tetrahymena have been worked out in detail, yielding both. a defined medium for growing the cells (9) and useful information for hypothesizing about metabolic pathways in this organism.
Tetrahymena and the growing rat have identical amino acid requirements (9, 10) . For both organisms, the phenylalanine requirement is approximately halved when the nonessential amino acid tyrosine is included in the diet (9, 11) . Also, at low enough concentrations of phenylalanine, growth in Tetrahynmna becomes dependent on tyrosine supplementation (12) .
These clues suggested that the conversion of phenylalanine to tyrosine in this ciliate resembles the mammalian pathway.
In the present paper, we report the isolation of tyrosine auxotrophs in Tetrahymena thermophila; as such, these mutants may be considered to be "phenylketonuric." Our biochemical and genetic complementation studies indicate that at least seven different kinds of defects can block the phenylalanine-to-tyrosine conversion in this organism. Several mutations, all in the same locus, cause the lack ofphenylalanine hydroxylase activity. Another mutant lacks dihydropteridine reductase. The growth of other mutants at several different loci is stimulated by 6-methyltetrahydropterine, and they are probably blocked in the unconjugated pteridine biosynthetic pathway.
MATERIALS AND METHODS
Strains. Cells of inbred strain B T. thernophila [formerly T. pyriformis, syngen 1 (13)] were used in all experiments. Stock maintenance and-other routine procedures have been described in detail (8, 14, 15) .
Media. A modification (16) ofthe chemically defined medium of Holz et al. (17) was primarily used to test auxotrophy; when necessary, defined medium was supplemented with 1.1 mM tyrosine (defined medium/Tyr). Two complex media were used for routine growth ofcultures: PP210, consisting of2% proteose peptone (Difco) supplemented with 10 ,uM ferric chloride; and PP110.15, consisting of 1% proteose peptone supplemented with 10 ,uM ferric chloride and 0.15% yeast extract (Difco). Proteose peptone media contain sufficient tyrosine to allow for normal growth ofthe auxotrophs. Penicillin G and streptomycin sulfate (Sigma), each at 250 kkg/ml, were added to all the above nutrient media to help prevent bacterial contamination. Unless otherwise indicated, cells were grown in 10-20 ml of medium without shaking, in 100 x 15 mm sterile disposable Petri dishes (Plasta-Medic).
Cells were washed and assayed in 10 mM or 50 mM Tris-HCl at pH 7.5 (Sigma) (15) .
Mutant Isolation. SB210 cells were exposed to nitrosoguanidine and crossed to CU329 cells. Self-fertilization (cytogamy) was induced in most ofthe pairs by giving a hyperosmotic shock with 1.5% glucose at 5 hr after the starved cells were mixed (18) . Self-fertilized progeny derive their nuclear genetic information from a single haploid meiotic product and hence become homozygous at every locus (14) . Progeny were cloned in 96-well plates under conditions that select for self-fertilized progeny, exploiting the recessiveness of the 2-deoxygalactose-resistance mutation (19 (24) . The reaction clearly was dependent on the presence of the pteridine cofactor and somewhat independent of components that in a purified rat liver system, play a role in the regeneration of the tetrahydro cofactor (NADP, NADPH, NAD, or NADH and its regenerating system glucose dehydrogenase and glucose; or chemical reduction by ascorbate) ( Table   2 ). Fairly high concentrations of MePteH4 (4 mM) were required for optimal conversion ofphenylalanine to tyrosine, even under such reducing conditions. The latter two observations indicate that the cofactor may not be recycling to any great extent in our crude system. MePteH4 was a much more effective cofactor for Tetrahymena phenylalanine hydroxylase than was 6,7-dimethyl-5,6,7,8-tetrahydropterin (Calbiochem) . No significant difference in activity was observed when NADPH, NAD, or NADH replaced NADP or upon addition of catalase or protease inhibitors to the assay (unpublished data). The substrate L-phenylalanine significantly protected the enzyme upon cell disruption (Table 2) .
Results of phenylalanine hydroxylase assays for each of the tyrosine auxotrophs are shown in Table 1 . All four mutants in the tyrC locus had little if any phenylalanine hydroxylase activity; the other mutants had levels close to or higher than wildtype levels. The wild-type hydroxylase showed full activity in the presence of mutant C3 extract; thus, this auxotroph does not contain an inhibitory substance but rather lacks a functional phenylalanine hydroxylase (unpublished data). Mutant tyrC16 was stimulated in vivo by high concentrations of phenylalanine (18 mM) , and may well be a "Kn" mutant. Two sterile mutants (not shown) also lacked phenylalanine hydroxylase activity. Mixture ofextracts ofone ofthese with mutant C3 extracts failed to restore activity. Unpublished genetic evidence suggests that at least two mutant sites are represented among the four fertile mutants. We suggest that tyrC is the structural (rather than a regulatory) gene for the phenylalanine hydroxylase because, among the large variety of mutants and loci already identified, mutants at only that locus lack phenylalanine hydroxylase activity.
The increases in phenylalanine hydroxylase activity seen in most ofthe other mutants were slight but reproducible and may (25) measures the NADH-dependent reduction of "quinonoid" 6,7-dimethyldihydropterin to the tetrahydro form. Tyrosine auxotroph 15 had greatly decreased levels of reductase; all the other mutants showed levels close to wild type. Mutant 15 responded well in vivo to the addition of ascorbate or increased levels of iron salts (Table 1) .
Because human tyrosine auxotrophs can be deficient in pteridine cofactor biosynthesis (5), we screened our mutants for growth stimulation (in the absence of tyrosine) by MePteH4, a relatively stable analog of the natural cofactor (26) . Mutants in at least three different loci (B, D, and F) showed varying (but nevertheless significant and repeatable) degrees of stimulation (Tables 1 and 3 Table 1 showed growth stimulation by 18 mM phenylalanine in defined medium (10-fold higher than normal) in the absence oftyrosine. This suggests that few (ifany) of our mutants are "pseudo-tyrosine-auxotrophs" due to a primary defect in phenylalanine uptake.
DISCUSSION
Nineteen tyrosine auxotrophs of the unicellular eukaryote T. thermophila, distributed among at least seven complementaProc. Nad Acad. Sci. USA 78 (1981) (24)]. Other percentages represent averages of at least two reactions. Only the tyrosine and phenylalanine regions of the chromatogram contained radioactivity significantly higher than background; at least 89% of the total radioactivity spotted was generally recovered in these two bands. Given the range of experimental error, 5% is probably the limit of sensitivity of the assay. Conversion was linear with time and amount of extract under the assay conditions. tion groups, have been obtained. Mutations in one locus (tyrC) cause the loss ofphenylalanine hydroxylase activity. A mutation in another locus (tyrG, tentatively) results in little or no dihydropteridine reductase. Effects of mutations in at least three loci (tyrB, -D, and -F, respectively) are phenotypically reversed (at least partially) by addition ofa tetrahydropterin to the growth medium; at least some of those mutants may be blocked in unconjugated pteridine biosynthesis. The meaning of the growth response of some of these mutants to iron salts remains to be elucidated.
The rat liver system has been invaluable as a model in this investigation of the conversion of phenylalanine to tyrosine in Tetrahymena. Several observations made here suggest a strong parallel between the two systems. First, several loci have been identified in both systems, indicative of the biochemical complexity that surrounds, more or less specifically, the hydroxylation of phenylalanine. Second, a phenylalanine hydroxylase has been identified in Tetrahymena with activity comparable to that of crude liver extracts. By using Kaufman and Levenberg's data for rat liver enzyme (phenylalanine hydroxylase) response to MePteH4 (26) and assuming a 59-fold purification of this enzyme (23) , tyrosine yield from a crude extract should be approximately 76 nmol/mg of protein per 30 min, whereas the Tetrahymena yield from under similar conditions is 29 nmol.
A third analogy between Tetrahymena and mammalian liver is the participation of a reduced unconjugated pteridine cofactor, as indicated by the MePteH4 requirement in the phenylalanine hydroxylase assay (Table 2) , the growth response of mutants affected in several loci to MePteH4 (Tables 1 and 3) , Kidder and Dewey (27) have shown that Tetrahymena synthesizes a compound that fulfills the unconjugated pteridine requirement for Crithidia fasciculata (28) . This pteridine, named "ciliapterin," appears to differ from the mammalian cofactor only in its side chain configuration [L-threo instead of Lerythro (27) ]. Barak (29) concluded that, in T. pyriformis, ciliapterin is the cofactor of choice for both the phenylalanine and tyrosine hydroxylases, with a dihydropteridine reductase converting dihydrociliapterin to its active tetrahydro form. Experiments with our pteridine-responding mutants may prove useful for the further investigation of Tetrahymena's natural hydroxylation cofactor and its corresponding reductase. These mutants may also prove useful for elucidating the unconjugated pteridine biosynthetic pathway. Ofadditional interest is the fact that Tetrahymena has a catecholamine synthesis pathway (30) resembling the mammalian pathway in that it also starts from tyrosine, although the detailed correspondence has been questioned (31) . Because in mammalian cells the hydroxylation of tyrosine (in the catecholamine pathway) and tryptophan (in the serotonin pathway) requires the same cofactor and reductase as the hydroxylation of phenylalanine, it seems quite likely that some of the mutants described here may be deficient also in the synthesis of these compounds.
The role ofcatecholamines in Tetrahymena has not been well described, although it is likely that these cells possess an adrenergic metabolic control system (32) . Catecholamines have been implicated in Tetrahymena carbohydrate metabolism (32) and, more specifically, in galactokinase regulation (33) . Some of the tyrosine auxotrophs isolated may be useful for experimental manipulation of catecholamine levels in Tetrahymena and might help to elucidate general aspects of the synthesis, metabolism, function, regulation, and dispensability of these messengers. The ease of biochemical manipulation of Tetrahymena makes it ideally suited for such a study.
The technology for efficiently isolating and examining more tyrosine as well as other types of auxotrophs is now available. Other laboratories have already isolated proline (34) and unsaturated fatty acid (35) auxotrophs, but these have not been characterized genetically. We have isolated several proline, cysteine, and thymidine auxotrophs from the same population of mutagen-treated progeny as the tyrosine auxotrophs; these have not yet been investigated.
Although the biochemical and clinical aspects of phenylketonuria have been extensively studied (6), further examination Cell Biology: Sanford and Orias of these "phenylketonuric" Tetrahymena seems worthwhile. Primarily, this ciliate system allows for a quick and easy genetic dissection ofthe reaction, perhaps yielding relevant information about the hereditary aspects of this complex disease. These cells, which grow rapidly (2.2-hr generation time) to a high density (106/ml) in complex medium, are a potential source of inexpensive extracts and compounds which may be useful in diagnosing or treating phenylketonuria. Finally, because these eukaryotes are so amenable to biochemical analysis, they may help to determine whether natural unconjugated pteridines, dihydropteridine reductase, or other phenylalanine hydroxylation components have other metabolic roles in the cell. For example, pteridines appear to be involved in the biosynthesis of unsaturated fatty acids, sterols, and pyrimidines in the flagellate Crithidiafasciculata (36) . Ifbiopterin-deficient phenylketonurics have similar metabolic defects, such knowledge may be instrumental in designing the most effective clinical treatment.
